Carlyle’s Abacus Pharma set to boost its capacity in East Africa
The East African leader in pharmaceutical distribution is scaling up its operations, both in terms of its core business and production.
Someone shares this article with you
▪ Carlyle’s Abacus Pharma set to boost its capacity in East Africa
▪ The East African leader in pharmaceutical distribution is scaling up its operations, both in terms of its core business and production.
09/12/2020 at 18h46, by Jeune Afrique Business+, updated 10/12/2020
Two areas of development are in the pipeline for AK Life Sciences Limited – better known under its brand name, Abacus Pharma – the Ugandan company sold by pan-African company AfricInvest to The Carlyle Group ($221bn under management) in September 2018. The initial priority concerns a strengthening of Abacus’ core business – drug distribution. Accustomed to transporting items produced in China and India to its African markets, the group plans to reinforce its regional network by renting new warehouses beyond those it already owns in Uganda (its main asset, measuring over 4,000 sqm), Tanzania and Burundi.
Any questions ? contact us
Please get in touch with the Jeune Afrique Business+ team if you require any further information.
Email us : email@example.com
Add JAB+ to your home screen
1. Click on at the bottom of your screen.
2. Click on to add JAB+ on the home screen.
3. Enter the name of the shortcut and confirm.